Medications

Targeting inflammatory protein could treat severe asthma

Just weeks after news of a sharp national spike in asthma deaths—with South Australia recording the highest increase in a single year (88%)—scientists have revealed a promising new treatment for the chronic lung disease.

Immunology

Spring allergies have wide-ranging effects, say experts

Spring allergies bring to mind thoughts of stuffy noses and watery eyes. But allergies actually affect many different and interconnected systems within a person's body, according to the American College of Allergy, Asthma ...

page 1 from 40

Asthma (from the Greek άσθμα, ásthma, "panting") is the common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include wheezing, coughing, chest tightness, and shortness of breath. Asthma is clinically classified according to the frequency of symptoms, forced expiratory volume in 1 second (FEV1), and peak expiratory flow rate. Asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic).

It is thought to be caused by a combination of genetic and environmental factors. Treatment of acute symptoms is usually with an inhaled short-acting beta-2 agonist (such as salbutamol). Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by inhaling corticosteroids. Leukotriene antagonists are less effective than corticosteroids and thus less preferred.

Its diagnosis is usually made based on the pattern of symptoms and/or response to therapy over time. The prevalence of asthma has increased significantly since the 1970s. As of 2010, 300 million people were affected worldwide. In 2009 asthma caused 250,000 deaths globally. Despite this, with proper control of asthma with step down therapy, prognosis is generally good.

This text uses material from Wikipedia licensed under CC BY-SA